Literature DB >> 16686672

Sodium channel variants in heart disease: expanding horizons.

Hanno L Tan1.   

Abstract

Inherited arrhythmia syndromes have advanced our understanding of cardiac sodium (Na) channel function in health and disease. Long QT syndrome (LQT3) is consistently caused by increased net Na current secondary to inactivation defects, which give rise to persistent Na current. Conversely, various gating changes that ultimately result in reduced Na current may elicit Brugada syndrome, conduction disease, atrial standstill, and sinus node disease. Emerging insights now also link these gating defects to enhanced arrhythmia susceptibility in common, acquired, disease. For instance, action potential prolongation in congestive heart failure may be explained by increased persistent Na current. Of note, recent studies have also linked Na current reduction to structural cardiac defects, notably cardiac fibrosis, dilated cardiomyopathy and, possibly, arrhythmogenic right ventricular cardiomyopathy. These structural changes may also be conducive to (reentrant) arrhythmias. Clearly, these observations highlight the cardiac Na channel as an interesting target for novel therapy strategies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16686672     DOI: 10.1111/j.1540-8167.2006.00398.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  10 in total

1.  Genetic basis of Brugada syndrome.

Authors:  Charles Antzelevitch
Journal:  Heart Rhythm       Date:  2007-03-23       Impact factor: 6.343

2.  Functionally distinct sodium channels in ventricular epicardial and endocardial cells contribute to a greater sensitivity of the epicardium to electrical depression.

Authors:  J M Cordeiro; M Mazza; R Goodrow; N Ulahannan; C Antzelevitch; J M Di Diego
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-02       Impact factor: 4.733

Review 3.  Dysfunctional Nav1.5 channels due to SCN5A mutations.

Authors:  Dan Han; Hui Tan; Chaofeng Sun; Guoliang Li
Journal:  Exp Biol Med (Maywood)       Date:  2018-05-27

4.  The pathophysiological mechanism underlying Brugada syndrome: depolarization versus repolarization.

Authors:  Arthur A M Wilde; Pieter G Postema; José M Di Diego; Sami Viskin; Hiroshi Morita; Jeffrey M Fish; Charles Antzelevitch
Journal:  J Mol Cell Cardiol       Date:  2010-07-24       Impact factor: 5.000

Review 5.  Atrial fibrillation and Brugada syndrome.

Authors:  Johnson Francis; Charles Antzelevitch
Journal:  J Am Coll Cardiol       Date:  2008-03-25       Impact factor: 24.094

6.  Simulation of Ca-calmodulin-dependent protein kinase II on rabbit ventricular myocyte ion currents and action potentials.

Authors:  Eleonora Grandi; Jose L Puglisi; Stefan Wagner; Lars S Maier; Stefano Severi; Donald M Bers
Journal:  Biophys J       Date:  2007-08-17       Impact factor: 4.033

Review 7.  Brugada syndrome: recent advances and controversies.

Authors:  Charles Antzelevitch; Eyal Nof
Journal:  Curr Cardiol Rep       Date:  2008-09       Impact factor: 2.931

8.  Voltage-gated sodium channels: biophysics, pharmacology, and related channelopathies.

Authors:  Eleonora Savio-Galimberti; Michael H Gollob; Dawood Darbar
Journal:  Front Pharmacol       Date:  2012-07-11       Impact factor: 5.810

Review 9.  Gene and cell therapies for the failing heart to prevent sudden arrhythmic death.

Authors:  A A Sovari; S C Dudley
Journal:  Minerva Cardioangiol       Date:  2012-08       Impact factor: 1.347

10.  The cardiac sodium channel mutation delQKP 1507-1509 is associated with the expanding phenotypic spectrum of LQT3, conduction disorder, dilated cardiomyopathy, and high incidence of youth sudden death.

Authors:  Ruiming Shi; Yanmin Zhang; Chun Yang; Chen Huang; Xihui Zhou; Hua Qiang; Andrew A Grace; Christopher L-H Huang; Aiqun Ma
Journal:  Europace       Date:  2008-08-12       Impact factor: 5.214

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.